MMP9 and cholangiocarcinoma: Specifically, TNF-α stimulates NFκB, MAPK, and Akt signaling, which in turn triggers the release of matrix metalloproteinase-9 (MMP-9) and increases the invasiveness of CCA in vitro [33].